Back to Agenda
Accelerating Drug Development Through Innovation
Session Chair(s)
John Reites
Chief Executive Officer, THREAD, United States
There has been a lot of discussion recently around accelerating drug development via innovative trial design. This can lead to shortened timelines and bringing products to patients more quickly. There are a variety of stakeholders involved in the successful execution of these innovative plans. In this session, participants will be given a case study in which they have to create a solution leveraging innovative ideas that will have been highlighted by subject matter experts.
Learning Objective : Describe the application of innovative drug development methodologies.
Speaker(s)
John Reites
Chief Executive Officer, THREAD, United States
5 Ways to Move Digital Health Innovation from Pilot to Platform
Hassan Kadhim, MSC
Global Head, Clinical Trial Business Capabilities, Clinical Innovation/Industry , Bristol Myers Squibb, United States
Moving Digital Health in Clinical Trials Beyond the Concept
Have an account?